Book a demo
Fr
Close Menu
EN FR
Book a demo
Our expertise
How it works Science behind HALEO How we support you
Meet HALEO
About us Career
How can we help
Take our online free screener Refer us your employer
Become a partner
HALEO for healthcare professional HALEO for insurer HALEO for sleep apnea experts
110 - Content Hero

Does lack of sleep harm your organization?

Fr
Français
M121 - History Grid

The impact

There are 5 significant sleep-related business costs that are hurting your organization.
Let’s review each of them under the assumption
that your employees earn an average salary of
$80,000 per year.1

1. Increased productivity losses

Employees with poor sleep will miss work up to 3 times more often than good sleepers and have their productivity negatively impacted up to 46 days per year.1

Capture d’écran, le 2024-04-25 à 09.05.12

Over half of us (51%) suffer from poor sleep to some degree3, including the 19%2 of the general population that experience chronic insomnia. In professions with non-daytime schedules or rotating shifts, the chronic insomnia rate can be twice as high. No matter your organization, sleep-related issues are creating a real but often invisible productivity burden.

2. More frequent and higher disability leave costs

Poor sleepers are 4.6 times more likely to go on disability leave than good sleepers.4 With that in mind, it’s no wonder that 33% of all claimants experience chronic insomnia at the time they go on disability.4 

Capture d’écran, le 2024-04-25 à 09.05.21

Poor sleep has been shown by repeated studies to be strongly associated with mental health issues, including anxiety and depression.4

3. Increased absence-replacement costs

High rates of sleep-related absenteeism and disability leave also drive higher replacement costs for roles that require replacement workers when an employee doesn’t show up.

Capture d’écran, le 2024-04-25 à 09.05.35

4. More frequent and costly workplace accidents and errors

Poor sleep is responsible for nearly 25% of the total cost of all workplace accidents and errors.6 Being awake for 17 hours is similar to having a blood alcohol concentration (BAC) of 0.05%, while being awake for 24 hours is similar to having a BAC of 0.10%(above the legal limit of 0.08%).7

Capture d’écran, le 2024-04-25 à 09.40.00

Poor sleep drives a range of symptoms that have an insidious effect on safety, including difficulty concentrating and focusing as well as poor decision-making. 

5. Prescription medication costs

On average, roughly 10% of workers depend on prescription medication to sleep.8 In professions with non-daytime schedules or rotating shifts the prescription medication rate for sleep can be significantly higher.9

Capture d’écran, le 2024-04-25 à 09.06.06

 

109 - 2 Col | Media Card Stack List

The cost of lack of sleep for the entire working population

Total hard costs
Total population costs
00 - Typography

The HALEO Solution

HALEO is a therapist-led, clinically proven behavioural sleep health solution, designed to be deployed in organizations. It helps employees who need to sleep better, whether they’re plagued by insomnia, experiencing nightmares, working non-standard hours, or even adapting to the challenges of being a new parent. HALEO is a one-on-one professional solution delivered by licensed therapists as a virtual program, with no wait times and no travel times.

Best-in-class clinical outcomes:
  • Over 85%* of HALEO patients complete their treatment, compared to less than 50% with internet-based cognitive behavioural therapy (iCBT) and other self-guided solutions in real-world settings,10 and around 70%11 with traditional therapist-led interventions in the community.

  • Patients give HALEO a 90%* satisfaction score.

  • 94%* of HALEO patients no longer show clinically significant symptoms post-treatment, typically within 5 weeks.

    Our proprietary and exclusive Cognitive Behavioural Therapy for Insomnia (CBT-I) approach is proven and clinically validated. Thanks to its brief, engaging session format, the duration and burden of treatment are significantly reduced compared to a traditional, group therapy-based clinical setting.
*Percentage of individuals with moderate to severe symptoms during evaluation who no longer have clinically significant symptoms after treatment; clinical results for Q4 2020. 
104 - Statement

HALEO is designed to save employers money by keeping their people at work, with fewer injuries, fewer errors, and more focus.

M114 - Experts Grid

An investment

When we implement HALEO within an organization, we work with our customers to ensure a high rate of employee engagement. 

25%
of their workforce is engaged

Through clear communication and education for employees on the benefits and importance of good sleep, many HALEO customers are able to engage more than 25%. 

10x
ROI gain

Many HALEO customers’ achieve a return on investment of over 10 times the cost of the solution.

00 - Typography

Improved sleep leads
to improved mental health

With existing corporate wellness and mental health initiatives, ongoing stigma and preconceptions can mean employees are wary of making use of the resources available to them. The uptake of clinical mental-health solutions offered by employers is often well below 1%. Fortunately, employees are much less reluctant when it comes to enrolling in sleep programs, as it can be easier and less stigmatizing to talk about sleep habits than depression or other mental health concerns.
Furthermore, a large body of research demonstrates that improving sleep significantly improves symptoms of depression, anxiety, and other mental issues.
 
In real-world use, many HALEO customers achieve engagement rates of 25% or higher. Improved sleep leads to improved mental health 14 Understanding the hidden business costs of poor sleep By treating sleep, we can put employees on the path to improving their overall health and well-being, significantly reducing stress, as well as symptoms of depression and anxiety.
 
75% of individuals who enter our clinic with symptoms of insomnia, and who also show moderate to severe depression and/or anxiety, show significant clinical improvement of these symptoms by the end of treatment.

Does lack of sleep affect your organization?

We can help you! HALEO offers a solution that can enhance productivity and well-being through quality sleep. Schedule a discovery meeting by booking your time here:

I want to offer HALEO to my organization

 

00 - Typography

References

1 Daley, M., Morin, C. M., LeBlanc, M., Grégoire, J. P., Savard, J. (janv. 2009). «The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers». Sleep, 32(1):55-64. PMID : 19189779; PMCID : PMC2625324.

2 Morin, C. M., Vézina-Im, L. A., Ivers, H., Micoulaud-Franchi, J. A., Philip, P., Lamy, M., Savard, J. (janv. 2022). «Prevalent, incident, and persistent insomnia in a population-based cohort tested before (2018) and during the first-wave of COVID-19 pandemic (2020)», Sleep, 45(1):zsab258. doi : 10.1093/sleep/
zsab258. PMID : 34698868; PMCID : PMC8574325.
3 Robillard, R., Dion, K., Pennestri, M. H., Solomonova, E., Lee, E., Saad, M., Murkar, A., Godbout, R., Edwards, J.D., Quilty, L., Daros, A. R., Bhatla, R., Kendzerska, T. (fév. 2021). « Profiles of sleep changes during the COVID-19 pandemic: Demographic, behavioural and psychological factors », Journal of Sleep Research, 30(1):e13231. doi : 10.1111/jsr.13231. Epub 17 novembre 2020. PMID : 33200477; PMCID : PMC7744844.
4 Sivertsen, B., Øverland, S., Pallesen, S., Bjorvatn, B., Nordhus, I. H., Maeland, J.G., Mykletun, A. (mars 2009). « Insomnia and long sleep duration are risk factors for later work disability. The Hordaland Health Study », Journal of Sleep Research, 18(1):122-128.  doi : 10.1111/j.1365-2869.2008.00697.x. Epub 13 octobre 2008. PMID : 19021852.
5 Scott, A. J., Webb, T. L., Martyn-St James, M., Rowse, G., Weich, S. (déc. 2021). « Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials », Sleep Medicine Reviews, 60:101556. doi: 10.1016/j. smrv.2021.101556. Epub 23 septembre 2021. PMID : 34607184; PMCID : PMC8651630.

6 Shahly, V., Berglund, P. A., Coulouvrat, C., Fitzgerald, T., Hajak, G., Roth, T., Shillington, A. C., Stephenson, J. J., Walsh, J. K., Kessler, R. C. (oct. 2012). «The associations of insomnia with costly workplace accidents and errors: results from the America Insomnia Survey», Archives of General Psychiatry,
69(10):1054-1063. doi : 10.1001/ archgenpsychiatry.2011.2188. PMID : 23026955.

7 Arnedt, J. T., Owens, J., Crouch, M., Stahl, J., Carskadon, M. A. (2005). « Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion », JAMA, 294:1025-1033. Dawson, D. et Reid, K. (1997). «Fatigue, alcohol and performance impairment», Nature, 388:235. Williamson, A. M. et Feyer, A. M. (2000). « Moderate sleep deprivation produces impairments in cognitive and motor performance equivalent
to legally prescribed levels of alcohol intoxication », Occupational and Environmental Medicine, 57:649-655.

8 National Center for Health Statistics (2020). National Health Interview Survey.

9 Tucker, P., Härmä, M., Ojajärvi, A., Kivimäki, M., Leineweber, C., Oksanen, T., Salo, P., Vahtera, J. (déc. 2021). « Association of rotating shift work schedules and the use of prescribed sleep medication: A prospective cohort study », Journal of Sleep Research, 30(6):e13349. doi : 10.1111/jsr.13349. Epub 14 juin 2021. PMID : 34128266.

10 L’étude porte sur la TCC en face à face (et non sur l’insomnie) et nous avons
un taux d’achèvement de 85 % (Fernandez et coll., 2015). Ritterband, L. M., Thorndike, F. P., Morin, C. M., Gerwien, R., Enman, N. M., Xiong, R., Luderer, H. F., Edington, S., Braun, S., Maricich, Y.A. (juin 2022). «Real-world evidence from users of a behavioral digital therapeutic for chronic insomnia», Behaviour Research and Therapy, 153:104084. doi : 10.1016/j.brat.2022.104084. Epub 1er avril 2022. PMID : 35405424.

11 Ong, J. C., Kuo, T. F., Manber, R. (avr. 2008). « Who is at risk for dropout from group cognitive- behavior therapy for insomnia? », Journal of Psychosomatic Research, 64(4):419-425. doi : 10.1016/j.jpsychores.2007.10.009. PMID : 18374742; PMCID: PMC2435302.
Lorem ipsum
Lorem ipsum
Fr
Français
Fr
Français